Phibro Animal Health shares are trading lower after the company reported worse-than-expected Q1 financial results. Also, Morgan Stanley maintained an Equal-Weight rating on the stock and lowered its price target from $17 to $16.
Benzinga Newsdesk - Nov 9, 2023, 11:07AM